Denmark · Seed startup

Who invested in Draupnir Bio

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$13Mraised across 1 round since 2024, from 1 source

Latest round
Seed, $13MJul 2024
Investors
2
See who backed them

The rounds

  1. Jul 2024

Founders and team

From Draupnir Bio's own website: 2 founders, 5 on the team.

Simon GlerupCo-Founder and Chief Scientific Officer
Camilla GustafsenCo-Founder and VP Biology
  • Andrew HotchkissChief Executive Officer
  • Casper Tind HansenChief Business Officer
  • Line SlemmingVP Legal & Corporate Affairs
  • Eva-Lotta AllanChair of the Board
  • Rob ScottIndependent Director

Everyone who backed them

Novo HoldingsVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Draupnir Bio as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

InkefVC firmPer its own site

Quick answers about Draupnir Bio

Who invested in Draupnir Bio?

Draupnir Bio's investors include Novo Holdings and Export and Investment Fund.

How much has Draupnir Bio raised?

Draupnir Bio has raised $13M across 1 round since 2024.

When did Draupnir Bio last raise?

Draupnir Bio's most recent round was a Seed of $13M in Jul 2024.

What was Draupnir Bio's biggest round?

Its most recent round, $13M in Jul 2024, is also its largest on record.

Who backed Draupnir Bio first?

Draupnir Bio's first round on record, in Jul 2024, was backed by Novo Holdings and Export and Investment Fund.

What stage is Draupnir Bio at?

Draupnir Bio's latest named round is a Seed, in Jul 2024.

Where is Draupnir Bio based?

Draupnir Bio is based in Denmark.

Companies like Draupnir Bio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.